Free shipping on orders over $69 and all Automatic Resupply orders!

Bone Health Support Combo

Bone Health Support Combo

Starburst SAVE 25% with this combo


Just $29.93

Add to Cart

Your satisfaction is 100% guaranteed

Bone Health Support Combo

For women, strong, flexible bones are critical to having good health. Along the way, your bone health status can change, affecting your health, and potentially your future. You can do a lot for your bones by working with your body to support your bones’ natural breakdown/buildup cycle so you stay strong, vital and active. Our Bone Health Support Combo is based on the latest science for creating and maintaining good, lasting bone health. Better Bones Basics, developed by natural bone health expert, Dr. Susan Brown, PhD, is the supplemental cal-mag every woman needs with the extra targeted vitamins and minerals healthy bones require. Essential fatty acids (EFAs) in the form of Omega-3s have powerful and beneficial effects on bone metabolism and overall bone health. Together, these two supplements can magnify the bone support you provide.

What you get with the Combo:

Better Bone Basics — our exclusive osteo support formula provides key bone health nutrients in the right amounts for everyday use. With ideal amounts of vitamin D, calcium and magnesium, Better Bones Basics is formulated to safely and effectively support women’s bone health. This efficient supplement also includes essential bone-building minerals at therapeutic levels, along with nutrients to optimize absorption and bone-building support.

Better Bones Basics includes:

  • Calcium — this essential nutrient is crucial for bone development and strength. We provide it as a carbonate/citrate complex in proper ratio to magnesium.
  • Magnesium — this important mineral helps your body absorb calcium and is used by many systems throughout your body for many processes. It’s instrumental in assuring bone strength and firmness. Also important to keep your teeth hard and strong.
  • Vitamin D3 — as research reveals more and more of its benefits, vitamin D3 as cholecalciferol continues to be one of the most important nutrients you can take. For best results, D3 levels should remain as consistent as possible, so daily use is advised.
  • Vitamin K1 and K2 — K1 plays a key role in blood clotting, and binds calcium to the skeleton while keeping calcium out of the arteries. K2 works to build bone strength and supports overall wellness.
  • Trace minerals — as manganese, boron, and zinc, these minerals are utilized in your body’s natural bone repair processes and are absolutely essential for good bone health and mineral absorption.

Our Omega-3s — these are molecularly distilled to concentrate the specific essential fatty acids in the formula. O3s can help reduce triglycerides and promote healthy bones (especially for women in menopause), eyes, skin, heart and joints. Omega-3s also promote emotional wellbeing and help decrease mood swings.

Our Omega-3s include:

  • Eicosapentaenoic acid (EPA) — as a key essential fatty acid, EPA supports heart and circulatory health.
  • Docosahexaenoic acid (DHA) — another essential fatty acid, DHA supports brain development and is critically important for optimal brain health and function.
  • Proper ratio of EPA to DHA to support heart, brain and circulatory health, and other body systems.

How to use:

For daily bone support, we recommend taking both Better Bones Basics and Omega-3s together regularly every day as directed. For best results and optimal nutrient absorption, you can take one dose of each supplement in the morning, and another at lunch or dinner.

This Bone Health Support Combo is intended to last a full 30 days.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Bone Health Support Combo Ingredients

Product References

Better Bones Basics

Our Better Bones Basics is formulated by Dr. Susan E. Brown, PhD, medical anthropologist and osteoporosis expert, using the latest nutritional and medical science for women’s bone health. For information on the clinical basis for using Better Bones Basics, click on each individual nutrient below to review a list of pertinent studies and articles, arranged in order of recency.


Our Omega-3s is doctor-formulated to be complete, natural, bioavailable, and manufactured to pharmaceutical standards.

The following articles and studies, arranged in order of recency, provide information concerning the clinical basis for using Omega-3s.

Bays, H. 2007. Safety considerations with omega-3 fatty acid therapy. Am. J. Cardiol., 99 (6A), 35C–43C.

Bourre, J. 2007. Dietary omega–3 fatty acids for women. Biomed. Pharmacother., 61 (3), 105–112.

Conklin, S., et al. 2007. Serum w-3 fatty acids are associated with variation in mood, personality and behavior in hypercholesterolemic community volunteers. Psych. Res., 152, 1–10.

Goldberg, R., & Katz, J. 2007. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain, 129, 210–223.

Nguyen, C., et al. 2007. Dietary omega 3 fatty acids decrease intraocular pressure with age by increasing aqueous outflow. Invest. Ophthalmol. Vis. Sci., 48 (2), 756–762.

Natural Standard Monograph. 2007. Omega-3 fatty acids, fish oil, alpha-linolenic acid. URL (limited access):

Townend, B., et al. 2007. Dietary macronutrient intake and five-year incident cataract: The Blue Mountains Eye Study. Am. J. Ophthalmol., 143, 932–939.

Appleton, K., et al. 2006. Effects of n-3 long-chain polyunsaturated fatty acids on depressed mood: Systematic review of published trials. Am. J. Clin. Nutr., 84, 1308–1316.

Black, H., & Rhodes, L. 2006. The potential of omega-3 fatty acids in the prevention of non-melanoma skin cancer. Cancer Detect. Prev., 30 (3), 224–232.

Creuzot, C., et al. 2006. [Improvement of dry eye symptoms with polyunsaturated fatty acids.] J. Fr. Ophtalmol., 29 (8), 868–873.

Freeman, M., et al. 2006. Omega-3 fatty acids: Evidence basis for treatment and future research in psychiatry. J. Clin. Psych., 67 (12), 1954–1967.

German, O., et al. 2006. Docosahexaenoic acid prevents apoptosis of retina photoreceptors by activating the ERK/MAPK pathway. J. Neurochem., 98, 1507–1520.

Kamphuis, M., et al. 2006. Depression and cardiovascular mortality: A role for n-3 fatty acids? Am. J. Clin. Nutr., 84, 1513–1517.

Kim, H-H., et al. 2006. Photoprotective and anti-skin-aging effects of eicosapentaenoic acid in human skin in vivo. J. Lipid Res., 47, 921–930.

Lamotte, M., et al. 2006. A multi-country health-economic evaluation of highly concentrated n-3 polyunsaturated fatty acids in the secondary prevention after myocardial infarction. Herz., 31 (Suppl. 3), 74–82.

Menéndez, J., et al. 2006. HER2 (erbB-2)-targeted effects of the omega-3 polyunsaturated fatty acid, alpha-linolenic acid (ALA; 18:3n-3), in breast cancer cells: The “fat features” of the “Mediterranean diet” as an “anti-HER2 cocktail”. Clin. Transl. Oncol., 8 (11), 812–820.

Nemets, H., et al. 2006. Omega-3 treatment of childhood depression: A controlled, double-blind pilot study. Am. J. Psych., 163 (6), 1098–1100.

Seddon, J., et al. 2006. Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration. The US Twin Study of Age-Related Macular Degeneration. Arch. Ophthalmol., 124, 995–1001.

Severus, W. 2006. Effects of omega-3 polyunsaturated fatty acids on depression. Herz., 31 (Suppl. 3), 69–74.

Walzer, B., et al. 2006. Supplementation with omega-3 polyunsaturated fatty acids augments brachial artery dilation and blood flow during forearm contraction. Eur. J. Appl. Physiol., 97, 347–354.

Berbert, A., et al. 2005. Supplementation of fish oil and olive oil in patients with rheumatoid arthritis. Nutrition, 21, 131–136.

Kim, H-H., et al. 2005. Eicosapentaenoic acid inhibits UV-induced MMP-1 expression in human dermal fibroblasts. J. Lipid Res., 46, 1712–1720.

Lerman, R. 2005. Essential fatty acids. In Textbook of Functional Medicine, ed. D. S. Jones & S. Quinn, pp. 420–433. Gig Harbor, WA: The Institute for Functional Medicine.

Covington, M. 2004. Omega-3 fatty acids. Am. Fam. Phys., 70 (1), 133–140.

Iribarren, C., et al. 2004. Dietary intake of n-3, n-6 fatty acids and fish: Relationship with hostility in young adults — the CARDIA study. Eur. J. Clinc. Nutr., 58, 24–31.

Saldeen, P., & Saldeen, T. 2004. Women and omega-3 fatty acids. Obstet. Gynecol., 59 (10), 722–730.

US FDA/Center for Food Safety and Applied Nutrition. 2004. What you need to know about mercury in fish and shellfish. EPA-823-R-04-005. URL:

Harris, W., et al. 2003. Cardiovascular disease and long-chain omega-3 fatty acids. Curr. Opin. Lipidol., 14 (1), 9–14.

Helland, I., et al. 2003. Maternal supplementation with very long-chain n-3 fatty acids during pregnancy and lactation augments children’s IQ at 4 years of age. Pediatrics, 111 (1), E39-E44.

Logan, A. 2003. Neurobehavioral aspects of omega-3 fatty acids: Possible mechanisms and therapeutic value in major depression. Altern. Med. Rev., 8 (4), 410–425.

Zanarini, M., & Frankenburg, F. 2003. Omega-3 fatty acid treatment of women with borderline personality disorder: A double-blind, placebo-controlled pilot study. Am. J. Psych., 160, 167–169.

Bagga, D., et al. 2002. Long-chain n-3 to n-6 polyunsaturated fatty acid ratios in breast adipose tissue from women with and without breast cancer. Nutr. Cancer, 42, 180–185.

Carrie, I., et al. 2002. Docosahexaenoic acid-rich phospholipid supplementation: Effect on behavior, learning ability, and retinal function in control and n-3 polyunsaturated fatty acid deficient old mice. Nutr. Neurosci., 5 (1):43–52.

Hu, F., et al. 2002. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA, 287 (14), 1815–1821.

Nestel, P. et al. 2002. The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans. Am. J. Clin. Nutr., 76, 326–330.

Chen, L., et al. 2000. Effect of stable fish oil on arterial thrombogenesis, platelet aggregation, and superoxide dismutase activity. J. Cardiovasc. Pharmacol., 35 (3), 502–505.

Curtis, C., et al. 2000. n-3 fatty acids specifically modulate catabolic factors involved in articular cartilage degradation. J. Biol. Chem., 275 (2), 721–724.

Stark, K., et al. 2000. Effect of a fish-oil concentrate on serum lipids in postmenopausal women receiving and not receiving hormone replacement therapy in a placebo-controlled, double-blind trial. Am. J. Clin. Nutr., 72, 389–394.

Yamada, T., et al. 2000. Atherosclerosis and w-3 fatty acids in the populations of a fishing village and a farming village in Japan. Atherosclerosis, 153, 469–481.

Austin, M., et al. 1998. Hypertriglyceridemia as a cardiovascular risk factor. Am. J. Cardiol., 81 (4A), 7B–12B.

Kruger, M., et al. 1998. Calcium, gamma-linolenic acid, and eicosapentaenoic acid supplementation in senile osteoporosis. Aging [Milano], 10 (5), 385–394.

Berry, E. 1997. Dietary fatty acids in the management of diabetes mellitus. Am. J. Clin. Nutr., 66 (4 Suppl.), S991–S997.

Bruckner, G. 1997. Microcirculation, vitamin E and omega 3 fatty acids: An overview. Adv. Exp. Med. Biol., 415, 195–208.

Katayama, Y. Effect of long-term administration of ethyl eicosapentate (EPA-E) on local cerebral blood flow and glucose utilization in stroke-prone spontaneously hypertensive rats (SHRSP). Brain Res., 761 (2), 300–305.

Belluzzi, A., et al. 1996. Effect of an enteric-coated fish-oil preparation on relapses in Crohn’s disease. NEJM, 3334 (24), 1557–1560.

Caygill, C., et al. 1996. Fat, fish oil and cancer. Br. J. Cancer, 74, 159–164.

Harel, Z., et al. 1996. Supplementation with omega-3 polyunsaturated fatty acids in the management of dysmenorrhea in adolescents. Am J. Obstet. Gynecol., 171 (4), 1335–1338.

Lau, C-S., et al. 1995. Effects of fish oil on plasma fibrinolysis in patients with mild rheumatoid arthritis. Clin. Exp. Rheumatol., 13 (1), 87–90.

Suzukawa, et al. 1995. Effects of fish oil fatty acids on low density lipoprotein size, oxidizability, and uptake by macrophages. J. Lipid Res., 36, 473–484.

Geusens, P., et al. 1994. Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis. A 12–month, double-blind, controlled study. Arthritis Rheum., 37 (6), 824–829.

Kankaanpää, P., et al. 1993. Dietary fatty acids and allergy. Ann. Med., 31 (4), 282–287.

Escobar, S., et al. 1992. Topical fish oil in psoriasis — a controlled and blind study. Clin. Exp. Dermatol., 17 (3), 159–162.

Simopoulos, A. 1991. Omega-3 fatty acids in health and disease and in growth and development. Am. J. Clin. Nutr., 54 (3), 438–463.

Ellis, E., et al. 1990. Effect of fish oil n-3 fatty acids on cerebral microcirculation. Am. J. Physiol., 258 (6 Pt. 2), H1780–H1785.

Haglund, O., et al. 1990. Effects of a new fluid fish oil concentrate, ESKIMO-3, on triglycerides, cholesterol, fibrinogen and blood pressure. J. Intern. Med., 227 (5), 347–353.

van der Temple, H., et al. 1990. Effects of fish oil supplementation in rheumatoid arthritis. Ann. Rheum. Dis., 49, 76–80.

Black, K., et al. 1984. Eicosapentaenoic acid: Effect on brain prostaglandins, cerebral blood flow and edema in ischemic gerbils. Stroke, 15 (1), 65–69.

We are available M-F 9am-6pm EDT
 Call us at 1-800-448-4919